Literature DB >> 8044844

The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP.

J C Eads1, G Scapin, Y Xu, C Grubmeyer, J C Sacchettini.   

Abstract

The crystal structure of HGPRTase with bound GMP has been determined and refined to 2.5 A resolution. The enzyme has a core alpha/beta structure resembling the nucleotide-binding fold of dehydrogenases, and a second lobe composed of residues from the amino and carboxy termini. The GMP molecule binds in an anti conformation in a solvent-exposed cleft of the enzyme. Lys-165, which forms a hydrogen bond to O6 of GMP, appears to be critical for determining the specificity for guanine and hypoxanthine over adenine. The location of active site residues also provides evidence for a possible mechanism for general base-assisted HGPRTase catalysis. A rationalization of the effects on stability and activity of naturally occurring single amino acid mutations of HGPRTase is presented, including a discussion of several mutations at the active site that lead to Lesch-Nyhan syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044844     DOI: 10.1016/0092-8674(94)90301-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  33 in total

1.  Ligand-receptor docking with the Mining Minima optimizer.

Authors:  L David; R Luo; M K Gilson
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

2.  Expression of the Methanobacterium thermoautotrophicum hpt gene, encoding hypoxanthine (Guanine) phosphoribosyltransferase, in Escherichia coli.

Authors:  J Sauer; P Nygaard
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

3.  Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs.

Authors:  A E Eakin; A Guerra; P J Focia; J Torres-Martinez; S P Craig
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Pyrophosphate activation in hypoxanthine--guanine phosphoribosyltransferase with transition state analogue.

Authors:  Hua Deng; Robert Callender; Vern L Schramm; Charles Grubmeyer
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

5.  Crystal structure of a predicted phosphoribosyltransferase (TT1426) from Thermus thermophilus HB8 at 2.01 A resolution.

Authors:  Mutsuko Kukimoto-Niino; Rie Shibata; Kazutaka Murayama; Hiroaki Hamana; Madoka Nishimoto; Yoshitaka Bessho; Takaho Terada; Mikako Shirouzu; Seiki Kuramitsu; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

6.  Structure of a GDP:AlF4 complex of the SRP GTPases Ffh and FtsY, and identification of a peripheral nucleotide interaction site.

Authors:  Pamela J Focia; Joseph Gawronski-Salerno; John S Coon; Douglas M Freymann
Journal:  J Mol Biol       Date:  2006-05-26       Impact factor: 5.469

7.  Structure of Salmonella typhimurium OMP synthase in a complete substrate complex.

Authors:  Charles Grubmeyer; Michael Riis Hansen; Alexander A Fedorov; Steven C Almo
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

8.  Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase.

Authors:  Hang-Korng Ea; Thomas Bardin; H A Jinnah; Bernard Aral; Frédéric Lioté; Irène Ceballos-Picot
Journal:  Arthritis Rheum       Date:  2009-07

9.  Identifying functionally informative evolutionary sequence profiles.

Authors:  Nelson Gil; Andras Fiser
Journal:  Bioinformatics       Date:  2018-04-15       Impact factor: 6.937

10.  Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding.

Authors:  M A Schumacher; D Carter; D M Scott; D S Roos; B Ullman; R G Brennan
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.